Biblio

Found 41 results
Filters: Author is Porreca, Frank  [Clear All Filters]
2023
Ito H, Navratilova E, Vagnerova B, Watanabe M, Kopruszinski C, de Souza LHMoreira, Yue X, Ikegami D, Moutal A, Patwardhan A et al..  2023.  Chronic pain recruits hypothalamic dynorphin/kappa opioid receptor signalling to promote wakefulness and vigilance.. Brain. 146(3):1186-1199.
Ashina S, Terwindt GM, Steiner TJ, Lee MJi, Porreca F, Tassorelli C, Schwedt TJ, Jensen RH, Diener H-C, Lipton RB.  2023.  Medication overuse headache.. Nat Rev Dis Primers. 9(1):5.
2022
Martin L, Ibrahim M, Gomez K, Yu J, Cai S, Chew LA, Bellampalli SS, Moutal A, Largent-Milnes T, Porreca F et al..  2022.  Conotoxin contulakin-G engages a neurotensin receptor 2/R-type calcium channel (Cav2.3) pathway to mediate spinal antinociception.. Pain. 163(9):1751-1762.
Starling AJ, Cortez MM, Jarvis NR, Zhang N, Porreca F, Chong CD, Schwedt TJ.  2022.  Cutaneous heat and light-induced pain thresholds in post-traumatic headache attributed to mild traumatic brain injury.. Headache. 62(6):726-736.
Watanabe M, Kopruszinski CM, Moutal A, Ikegami D, Khanna R, Chen Y, Ross S, Mackenzie K, Stratton J, Dodick DW et al..  2022.  Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine.. Brain. 145(8):2894-2909.
Kopruszinski CMachado, Porreca F, Chichorro JGeremias.  2022.  Editorial: Chronic orofacial pain.. Front Pain Res (Lausanne). 3:1086256.
Kopruszinski CM, Vizin R, Watanabe M, Martinez AL, de Souza LHenrique M, Dodick DW, Porreca F, Navratilova E.  2022.  Exploring the neurobiology of the premonitory phase of migraine preclinically - a role for hypothalamic kappa opioid receptors? J Headache Pain. 23(1):126.
Yakhnitsa V, Ji G, Hein M, Presto P, Griffin Z, Ponomareva O, Navratilova E, Porreca F, Neugebauer V.  2022.  Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain.. Front Pharmacol. 13:903978.
Navratilova E, Oyarzo J, Anderson T, Broide RS, Subramaniam SR, Vazquez-Cintron EJ, Brin MF, Schwedt TJ, Dodick DW, Porreca F.  2022.  Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache.. Cephalalgia. 42(11-12):1194-1206.
Ikegami D, Navratilova E, Yue X, Moutal A, Kopruszinski CM, Khanna R, Patwardhan A, Dodick DW, Porreca F.  2022.  A prolactin-dependent sexually dimorphic mechanism of migraine chronification.. Cephalalgia. 42(3):197-208.
2021
Lançon K, Qu C, Navratilova E, Porreca F, Séguéla P.  2021.  Decreased dopaminergic inhibition of pyramidal neurons in anterior cingulate cortex maintains chronic neuropathic pain.. Cell Rep. 37(9):109933.
2019
Khanna R, Patwardhan A, Yang X, Li W, Cai S, Ji Y, Chew LA, Dorame A, Bellampalli SS, Schmoll RW et al..  2019.  Development and Characterization of An Injury-free Model of Functional Pain in Rats by Exposure to Red Light.. J Pain. 20(11):1293-1306.
2017
Xie JY, De Felice M, Kopruszinski CM, Eyde N, LaVigne J, Remeniuk B, Hernandez P, Yue X, Goshima N, Ossipov M et al..  2017.  Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.. Cephalalgia. 37(8):780-794.
Ibrahim MM, Patwardhan A, Gilbraith KB, Moutal A, Yang X, Chew LA, Largent-Milnes T, T Malan P, Vanderah TW, Porreca F et al..  2017.  Long-lasting antinociceptive effects of green light in acute and chronic pain in rats.. Pain. 158(2):347-360.
Remesic M, Hruby VJ, Porreca F, Lee YSun.  2017.  Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics.. ACS Chem Neurosci. 8(6):1147-1158.
2016
Lee YSun, Remesic M, Ramos-Colon C, Hall SM, Kuzmin A, Rankin D, Porreca F, Lai J, Hruby VJ.  2016.  Cyclic non-opioid dynorphin A analogues for the bradykinin receptors.. Bioorg Med Chem Lett. 26(22):5513-5516.
Hall SM, LeBaron L, Ramos-Colon C, Qu C, Xie JYanhua, Porreca F, Lai J, Lee YSun, Hruby VJ.  2016.  Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain.. ACS Chem Neurosci. 7(12):1746-1752.
Moutal A, Chew LA, Yang X, Wang Y, Yeon SKi, Telemi E, Meroueh S, Park KDuk, Shrinivasan R, Gilbraith KB et al..  2016.  (S)-Lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.. Pain.
Ramos-Colon CN, Lee YSun, Remesic M, Hall SM, LaVigne J, Davis P, Sandweiss AJ, McIntosh MI, Hanson J, Largent-Milnes TM et al..  2016.  Structure-Activity Relationships of [des-Arg(7)]Dynorphin A Analogues at the κ Opioid Receptor.. J Med Chem. 59(22):10291-10298.
Lee YSun, Kupp R, Remesic MV, Ramos-Colon C, Hall SM, Chan C, Rankin D, Lai J, Porreca F, Hruby VJ.  2016.  Various modifications of the amphipathic dynorphin A pharmacophore for rat brain bradykinin receptors.. Chem Biol Drug Des. 88(4):615-9.
2015
Lee YSun, Hall SM, Ramos-Colon C, Remesic M, Rankin D, Vanderah TW, Porreca F, Lai J, Hruby VJ.  2015.  Blockade of non-opioid excitatory effects of spinal dynorphin A at bradykinin receptors.. Receptors Clin Investig. 2(1)
Deekonda S, Wugalter L, Rankin D, Largent-Milnes TM, Davis P, Wang Y, BassiriRad NM, Lai J, Kulkarni V, Vanderah TW et al..  2015.  Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives.. Bioorg Med Chem Lett. 25(20):4683-8.
Deekonda S, Wugalter L, Kulkarni V, Rankin D, Largent-Milnes TM, Davis P, BassiriRad NM, Lai J, Vanderah TW, Porreca F et al..  2015.  Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands.. Bioorg Med Chem. 23(18):6185-94.
Giri AKumar, Apostol CR, Wang Y, Forte BL, Largent-Milnes TM, Davis P, Rankin D, Molnar G, Olson KM, Porreca F et al..  2015.  Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.. J Med Chem. 58(21):8573-83.
Little JW, Ford A, Symons-Liguori AM, Chen Z, Janes K, Doyle T, Xie J, Luongo L, Tosh DK, Maione S et al..  2015.  Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states.. Brain. 138(Pt 1):28-35.

Pages